These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 16901955

  • 1. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.
    Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Rönnelid J.
    Ann Rheum Dis; 2007 Jan; 66(1):59-64. PubMed ID: 16901955
    [Abstract] [Full Text] [Related]

  • 2. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C, Us T, Kaşifoğlu T, Akgün Y.
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [Abstract] [Full Text] [Related]

  • 3. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D, Gülmez D, Hasçelik G.
    Mikrobiyol Bul; 2003 Oct; 37(2-3):163-70. PubMed ID: 14593899
    [Abstract] [Full Text] [Related]

  • 4. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis.
    Alexiou I, Germenis A, Koutroumpas A, Kontogianni A, Theodoridou K, Sakkas LI.
    Clin Rheumatol; 2008 Apr; 27(4):511-3. PubMed ID: 18172572
    [Abstract] [Full Text] [Related]

  • 5. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [Abstract] [Full Text] [Related]

  • 6. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

  • 7. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [Abstract] [Full Text] [Related]

  • 8. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 9. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [Abstract] [Full Text] [Related]

  • 10. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 May; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 11. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 12. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 13. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 14. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis.
    Gonzalez-Lopez L, Rocha-Muñoz AD, Ponce-Guarneros M, Flores-Chavez A, Salazar-Paramo M, Nava A, Cardona-Muñoz EG, Fajardo-Robledo NS, Zavaleta-Muñiz SA, Garcia-Cobian T, Gamez-Nava JI.
    J Immunol Res; 2014 Feb 15; 2014():536050. PubMed ID: 24804270
    [Abstract] [Full Text] [Related]

  • 15. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Sène D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC, Cacoub P.
    Ann Rheum Dis; 2006 Mar 15; 65(3):394-7. PubMed ID: 16474032
    [Abstract] [Full Text] [Related]

  • 16. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 15; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 17. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.
    Bobbio-Pallavicini F, Alpini C, Caporali R, Avalle S, Bugatti S, Montecucco C.
    Arthritis Res Ther; 2004 Apr 15; 6(3):R264-72. PubMed ID: 15142273
    [Abstract] [Full Text] [Related]

  • 18. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb 15; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul 15; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 20. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
    Damián-Abrego GN, Cabiedes J, Cabral AR.
    Lupus; 2008 Apr 15; 17(4):300-4. PubMed ID: 18413411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.